Qinjie Weng

4.6k total citations · 3 hit papers
96 papers, 3.0k citations indexed

About

Qinjie Weng is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, Qinjie Weng has authored 96 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 16 papers in Immunology and 15 papers in Nephrology. Recurrent topics in Qinjie Weng's work include Renal Diseases and Glomerulopathies (12 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Immune cells in cancer (7 papers). Qinjie Weng is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Immune cells in cancer (7 papers). Qinjie Weng collaborates with scholars based in China, United States and Germany. Qinjie Weng's co-authors include Qiaojun He, Jiajia Wang, Bo Yang, Jincheng Wang, Hong Zhu, Bo Yang, Yueping Qiu, Chunyan Fang, Dayong Lou and Liqin Zhou and has published in prestigious journals such as Nature Communications, Neuron and The Journal of Cell Biology.

In The Last Decade

Qinjie Weng

88 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis

2021 283 citations Kaili Hu, Bo Yang et al. Acta Pharmaceutica Sinica B profile →
Natural products: potential treatments for cisplatin-induced nephrotoxicity

2021 258 citations Chunyan Fang, Dayong Lou et al. Acta Pharmacologica Sinica profile →
Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics

2021 223 citations Qinjie Weng, Jincheng Wang et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qinjie Weng China	29	1.3k	437	436	330	300	96	3.0k
Ting Zhang China	33	1.9k 1.4×	301 0.7×	385 0.9×	302 0.9×	334 1.1×	260	3.9k
Iok In Christine Chio United States	17	2.3k 1.7×	406 0.9×	801 1.8×	330 1.0×	236 0.8×	25	3.8k
Shan Lu China	36	1.8k 1.4×	412 0.9×	835 1.9×	189 0.6×	459 1.5×	89	3.5k
Konstantinos Evangelou Greece	27	1.6k 1.2×	431 1.0×	304 0.7×	148 0.4×	270 0.9×	65	3.0k
Yan Qiu China	32	1.9k 1.4×	285 0.7×	490 1.1×	106 0.3×	147 0.5×	95	3.4k
Ramandeep Rattan United States	34	2.1k 1.6×	395 0.9×	805 1.8×	201 0.6×	339 1.1×	81	3.4k
Kai Qu China	33	1.7k 1.3×	367 0.8×	776 1.8×	162 0.5×	364 1.2×	121	3.2k
Bartosz Szczęsny United States	34	2.0k 1.5×	345 0.8×	275 0.6×	207 0.6×	329 1.1×	62	3.7k
Jihye Paik United States	30	3.0k 2.3×	371 0.8×	583 1.3×	308 0.9×	623 2.1×	56	4.4k
Ye Xu China	32	1.3k 1.0×	206 0.5×	282 0.6×	114 0.3×	476 1.6×	77	2.5k

Countries citing papers authored by Qinjie Weng

Since Specialization

Citations

This map shows the geographic impact of Qinjie Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinjie Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinjie Weng more than expected).

Fields of papers citing papers by Qinjie Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinjie Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinjie Weng. The network helps show where Qinjie Weng may publish in the future.

Co-authorship network of co-authors of Qinjie Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Qinjie Weng. A scholar is included among the top collaborators of Qinjie Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinjie Weng. Qinjie Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Hongbo, Zhibin Li, Han Yin, et al.. (2025). Inhibition of EED-mediated histone methylation alleviates neuroinflammation by suppressing WNT-mediated dendritic cell migration. Journal of Neuroinflammation. 22(1). 97–97. 1 indexed citations

Wang, Jiaying, Jiaying Wang, Lijiang Zhang, et al.. (2025). Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis. Acta Pharmaceutica Sinica B. 15(3). 1626–1642.

Lai, Qi‐Lun, Meng‐Ting Cai, Guihua Fang, et al.. (2025). Neurofilament light chain levels in neuronal surface antibody-associated autoimmune encephalitis: a systematic review and meta-analysis. Translational Psychiatry. 15(1). 25–25.

Guo, Juan, Xiaoyu Li, Qinjie Weng, et al.. (2025). Refining Non‐Invasive Diagnosis of Diabetic Nephropathy: The Role of Renal Artery Resistive Index. Journal of Clinical Ultrasound. 53(9). 1956–1965.

Li, Guilin, Yang Chen, Jiajia Wang, et al.. (2024). Single-cell RNA sequencing reveals cell–cell communication and potential biomarker in sepsis and septic shock patients. International Immunopharmacology. 132. 111938–111938. 3 indexed citations

Wang, Jiajia, Jincheng Wang, Qinjie Weng, et al.. (2024). BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination. The Journal of Cell Biology. 223(7). 5 indexed citations

Jiang, Lan, Runkun Yang, Yongjun Wu, et al.. (2024). Effect of hydrogel drug delivery system for treating ulcerative colitis: A preclinical meta-analysis. International Journal of Pharmaceutics. 659. 124281–124281. 2 indexed citations

Hu, Yuming, Yang Chen, Ping Li, et al.. (2024). Isorhapontigenin alleviates acetaminophen-induced liver injury by promoting fatty acid oxidation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(2). 167575–167575. 3 indexed citations

Pan, Xiaohui, Hongjie Guo, Honghai Wu, et al.. (2023). KLF12 transcriptionally regulates PD‐L1 expression in non‐small cell lung cancer. Molecular Oncology. 17(12). 2659–2674. 7 indexed citations

10.

Du, Wen, Zijin Chen, Junru Li, et al.. (2023). Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis. Clinical Kidney Journal. 16(12). 2567–2577. 2 indexed citations

11.

Wang, Sheng, Renhua Gai, Xiaomeng Wang, et al.. (2023). Safety Evaluation of Curcumol by a Repeated Dose 28-Day Oral Exposure Toxicity Study in Rats. Toxics. 11(2). 114–114. 5 indexed citations

12.

Che, Jinxin, Dan Li, Yu Guo, et al.. (2022). Discovery of new macrophage M2 polarization modulators as multiple sclerosis treatment agents that enable the inflammation microenvironment remodeling. European Journal of Medicinal Chemistry. 243. 114732–114732. 8 indexed citations

13.

Zhang, Wenxin, Xi Chen, Honghai Wu, et al.. (2022). Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer. Biomedicine & Pharmacotherapy. 157. 114030–114030. 16 indexed citations

14.

Qiu, Yueping, Jincheng Wang, Jincheng Wang, et al.. (2021). Emerging views of OPTN (optineurin) function in the autophagic process associated with disease. Autophagy. 18(1). 73–85. 85 indexed citations

15.

Hu, Kaili, Bo Yang, Qiaojun He, et al.. (2021). Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharmaceutica Sinica B. 12(1). 18–32. 283 indexed citations breakdown →

16.

Fang, Chunyan, Dayong Lou, Liqin Zhou, et al.. (2021). Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacologica Sinica. 42(12). 1951–1969. 258 indexed citations breakdown →

17.

Cao, Ji, Rong Dong, Jiang Li, et al.. (2018). LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization. Cancer Immunology Research. 7(2). 292–305. 132 indexed citations

18.

Zhao, Chuntao, Yaqi Deng, Lei Liu, et al.. (2016). Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation. Nature Communications. 7(1). 10883–10883. 115 indexed citations

19.

Tan, Biqin, Mengting Zhao, Yan Hu, et al.. (2015). TCF7L2 activation is required for myelin regeneration in 5-FU-induced demyelinating mice. Toxicology Research. 4(6). 1597–1603. 1 indexed citations

20.

Weng, Qinjie, et al.. (2012). ANTI -INFLAMMATORY AND ANTI -NOCICEPTIVE ACTIVITIES OF THE EXTRACTS OF SARGENTODOXA CUNEATA AND ITS EFFECTS ON THE MODEL RATS WITH PELVIC INFLAMMATION. The Journal of Animal and Plant Sciences. 22(1). 44–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact